Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
JAMA. 2021 May 4;325(17):1744-1754. doi: 10.1001/jama.2021.4172.
JAMA. 2021.
PMID: 33944876
Free PMC article.
Clinical Trial.
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial.
Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G, Henriksen M, Hoie SS, Krogh J, Midtgard IP, Mielnik P, Moum B, Noraberg G, Poyan A, Prestegård U, Rashid HU, Strand EK, Skjetne K, Seeberg KA, Torp R, Ystrøm CM, Vold C, Zettel CC, Waksvik K, Gulbrandsen B, Hagfors J, Mørk C, Jahnsen J, Kvien TK.
Goll GL, et al. Among authors: zettel cc.
J Intern Med. 2019 Jun;285(6):653-669. doi: 10.1111/joim.12880. Epub 2019 Apr 12.
J Intern Med. 2019.
PMID: 30762274
Free PMC article.
Clinical Trial.
Item in Clipboard
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
Syversen SW, Jørgensen KK, Goll GL, Brun MK, Sandanger Ø, Bjørlykke KH, Sexton J, Olsen IC, Gehin JE, Warren DJ, Klaasen RA, Noraberg G, Bruun TJ, Dotterud CK, Ljoså MKA, Haugen AJ, Njålla RJ, Zettel C, Ystrøm CM, Bragnes YH, Skorpe S, Thune T, Seeberg KA, Michelsen B, Blomgren IM, Strand EK, Mielnik P, Torp R, Mørk C, Kvien TK, Jahnsen J, Bolstad N, Haavardsholm EA.
Syversen SW, et al. Among authors: zettel c.
JAMA. 2021 Dec 21;326(23):2375-2384. doi: 10.1001/jama.2021.21316.
JAMA. 2021.
PMID: 34932077
Free PMC article.
Clinical Trial.
Item in Clipboard
Exploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.
Brkic A, Diamantopoulos AP, Haavardsholm EA, Fevang BTS, Brekke LK, Loli L, Zettel C, Rødevand E, Bakland G, Mielnik P, Haugeberg G.
Brkic A, et al. Among authors: zettel c.
BMC Health Serv Res. 2022 Jan 10;22(1):48. doi: 10.1186/s12913-021-07425-w.
BMC Health Serv Res. 2022.
PMID: 35012522
Free PMC article.
Item in Clipboard
Exploring the impact of the national tender system on the use of costly drugs treating rheumatoid arthritis patients in ten rheumatology centers in Norway (2010-2019).
Brkic A, Diamantopoulos AP, Hoff M, Haavardsholm EA, Fevang BTS, Brekke LK, Loli L, Zettel C, Bakland G, Mielnik P, Haugeberg G.
Brkic A, et al. Among authors: zettel c.
BMC Health Serv Res. 2023 Sep 7;23(1):968. doi: 10.1186/s12913-023-09975-7.
BMC Health Serv Res. 2023.
PMID: 37679747
Free PMC article.
Item in Clipboard
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
Schuler CF 4th, Gherasim C, O'Shea K, Manthei DM, Chen J, Zettel C, Troost JP, Kennedy AA, Tai AW, Giacherio DA, Valdez R, Baldwin JL, Baker JR Jr.
Schuler CF 4th, et al. Among authors: zettel c.
Microbiol Spectr. 2021 Oct 31;9(2):e0008721. doi: 10.1128/Spectrum.00087-21. Epub 2021 Sep 1.
Microbiol Spectr. 2021.
PMID: 34468184
Free PMC article.
Item in Clipboard
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.
Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK; NOR-SWITCH study group.
Jørgensen KK, et al.
Lancet. 2017 Jun 10;389(10086):2304-2316. doi: 10.1016/S0140-6736(17)30068-5. Epub 2017 May 11.
Lancet. 2017.
PMID: 28502609
Clinical Trial.
Item in Clipboard
Cite
Cite